Allergy, airway hyperreactivity (AHR), and allergic asthma are risk factors of chronic obstructive pulmonary disease (COPD), a heterogeneous disease presenting with various phenotypes. An allergic phenotype of COPD, characterized by more severe respiratory symptoms and higher risk of acute exacerbations, was described recently.([1]) Further investigations into the role of allergy in the pathogenesis and/or expressions of COPD may lead to new modalities targeting the allergic component, a potentially treatable feature of a progressive disease like COPD.
基金：
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81470239]; High-level Talent Training Foundation of Beijing Health System [2014-3-011]
第一作者机构：[1]Capital Med Univ, Beijing Tongren Hosp, Dept Resp & Crit Care Med, Beijing 100730, Peoples R China
通讯作者：
通讯机构：[2]Peking Univ, Dept Resp & Crit Care Med, Hosp 3, Beijing 100191, Peoples R China[*1]Department of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing 100191, China
推荐引用方式(GB/T 7714)：
Jin Jian-Min,Sun Yong-Chang.Allergy and Chronic Obstructive Pulmonary Disease[J].CHINESE MEDICAL JOURNAL.2017,130(17):2017-2020.doi:10.4103/0366-6999.213427.
APA：
Jin, Jian-Min&Sun, Yong-Chang.(2017).Allergy and Chronic Obstructive Pulmonary Disease.CHINESE MEDICAL JOURNAL,130,(17)
MLA：
Jin, Jian-Min,et al."Allergy and Chronic Obstructive Pulmonary Disease".CHINESE MEDICAL JOURNAL 130..17(2017):2017-2020
